Sugi Predict

Sugi Predict / Compounds / SCHEMBL1477259

SCHEMBL1477259

SCHEMBL1477259

[CH2]CCCCC=CCC=CCC=CCC=CCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.52
▸ CYP19A1 P11511 4/20 0.52
▸ F7 P08709 3/20 0.52
▸ F3 P13726 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ OXER1 Q8TDS5 3/20 0.52
▸ PPARG P37231 3/20 0.52
▸ PTGS1 P23219 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ PPARD Q03181 2/20 0.52
▸ PPARA Q07869 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ NR1I2 O75469 2/20 0.52
▸ PTGS2 P35354 2/20 0.52
▸ FFAR1 O14842 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15057585 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL605503 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL1477257 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL15848146 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL605502 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL18300703 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL15848222 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL606193 1.00 ALDH1A1 (0.52) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL25185958 0.98 ALDH1A1 (0.55) ALDH1A1CYP19A1F7F3MAPT
SCHEMBL25185258 0.98 ALDH1A1 (0.55) ALDH1A1CYP19A1F7F3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1390378-B1 PHARMACEUTICALLY ACTIVE URIDINE ESTERS TROMMSDORFF ARZNEIMITTEL (DE) 2009-06-17 — — EP claimed
US-7396826-B2 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) 2008-07-08 — — US claimed
JP-2004531543-A — — 2004-10-14 — — JP claimed
US-20040121979-A1 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) 2004-06-24 — — US claimed
EP-1390378-A1 PHARMACEUTICALLY ACTIVE URIDINE ESTERS Trommsdorff GmbH & Co. KG Arzneimittel (DE) 2004-02-25 — — EP claimed
WO-2002088159-A1 PHARMACEUTICALLY ACTIVE URIDINE ESTERS TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) 2002-11-07 — — WO claimed
WO-2023211940-A1 STING AGONISTS, FORMULATIONS, AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-11-02 — — WO disclosed
WO-2023211934-A1 LIPIDS, FORMULATIONS, AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-11-02 — — WO disclosed
WO-2023211930-A1 DUAL FUNCTIONING IMMUNE MODULATING COMPOUNDS, FORMULATIONS, AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-11-02 — — WO disclosed
US-10759967-B2 Bitumen-polymer composition and method for the preparation thereof TOTAL MARKETING SERVICES (FR) 2020-09-01 — — US disclosed
US-10588962-B2 Carbohydrate-glycolipid conjugate vaccines MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2020-03-17 — — US disclosed
US-20180298233-A1 BITUMEN-POLYMER COMPOSITION AND METHOD FOR THE PREPARATION THEREOF TOTAL MARKETING SERVICES (FR) 2018-10-18 — — US disclosed
EP-3383945-A1 BITUMEN-POLYMER COMPOSITION AND METHOD FOR THE PREPARATION THEREOF Total Marketing Services (FR) 2018-10-10 — — EP disclosed
US-20050065110-A1 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO., KG ARZNEIMITTEL 2005-03-24 — — US disclosed
US-20050043394-A1 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL 2005-02-24 — — US disclosed
US-20050043269-A1 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL 2005-02-24 — — US disclosed
US-20040121979-A1 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) 2004-06-24 — — US disclosed
EP-1390378-A1 PHARMACEUTICALLY ACTIVE URIDINE ESTERS Trommsdorff GmbH & Co. KG Arzneimittel (DE) 2004-02-25 — — EP disclosed
WO-2002088159-A1 PHARMACEUTICALLY ACTIVE URIDINE ESTERS TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) 2002-11-07 — — WO disclosed
US-5120777-A Organonitrogen compound as coupler ELF FRANCE (FR) 1992-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043394-A1 Pharmaceutically active uridine esters UMPS, UGDH, FFAR3 ALDH1A1 342/4885CYP19A1 1191/4885F7 1255/4885
US-20040121979-A1 Pharmaceutically active uridine esters UMPS, UGDH, FFAR1 ALDH1A1 142/4885CYP19A1 958/4885F7 1183/4885
US-20050043269-A1 Pharmaceutically active uridine esters UMPS, UGDH, FFAR3 ALDH1A1 342/4885CYP19A1 1191/4885F7 1255/4885
US-20050065110-A1 Pharmaceutically active uridine esters UMPS, UGDH, FFAR3 ALDH1A1 342/4885CYP19A1 1191/4885F7 1255/4885
US-10588962-B2 Carbohydrate-glycolipid conjugate vaccines STT3B, STT3A, DDOST ALDH1A1 2693/4885CYP19A1 4080/4885F7 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.